Updated:
Pharmstandard International S.A.
Pharmstandard International S.A. is a family office with a global footprint in North America, Europe, and Australia.
Pharmstandard International S.A.
Pharmstandard International S.A. is structured as a family office with an international network of offices in San Francisco, New Brunswick, Indianapolis, Boston, Moscow, Larkspur, and Melbourne. The firm's name references the pharmaceutical sector, indicating a likely wealth origin tied to the industry, though no public disclosure confirms the specific family or founder. Its operations span multiple continents, suggesting a diversified global investment mandate. The firm allocates capital across direct equity investments, real estate holdings, and healthcare-related ventures. Likely asset classes include private equity in life sciences, commercial and residential real estate, and public market securities. While no specific portfolio companies or deals are publicly attributed, the geographic distribution of offices points to a strategy of regional exposure in the US, Europe, Russia, and Australia. Total deployment and team size are not publicly disclosed. The firm maintains a presence in Russia (Moscow), which may reflect legacy ties or ongoing operations. No philanthropic foundations or separate vehicles have been identified. No recent operational events within the last 24 months are verifiable from public sources. A structural differentiator is the firm's broad geographic dispersion combined with a name anchored to the pharmaceutical industry, suggesting a family office that evolved from an operating company. Whether the firm operates as a pure single-family office or a multi-family office remains unclear from public data. Its governance structure and investment committee composition are not publicly known.
General information
Firm type
Single Family Office
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
San Francisco
Corporate office
San Francisco, CA, United States
Additional offices
New Brunswick · Indianapolis · Boston · Moscow · Larkspur · Melbourne
Sector focus
Frequently asked questions
Who runs investment decisions at Pharmstandard International S.A.?
No individual principals or investment committee members are publicly named for this firm. The absence of disclosed leadership makes it difficult to assess decision-making structures. Allocations likely follow a mandate set by the founding family, but specific roles are not available from public records.
Is Pharmstandard International S.A. a single or multi-family office?
Based on its name and structure, it is likely a single-family office tied to wealth generated from the pharmaceutical industry. The firm has offices in seven cities across three continents, which could support either model. Without public confirmation, the subtype remains inferred (public record).
How does the firm's name relate to its investment focus?
The name 'Pharmstandard' strongly suggests a pharmaceutical industry origin. The firm may allocate capital to life sciences and healthcare as part of its core strategy, though confirmed portfolio holdings are not publicly disclosed. This sector alignment would be consistent with the wealth origin hypothesis.
Does Pharmstandard International S.A. participate in fund commitments or direct deals?
The firm's strategy is not publicly specified, but its multi-office setup and probable pharmaceutical background suggest both direct investments in operating companies and possibly fund commitments in private equity or real estate. No specific deal activity is verifiable from public sources.
What is the firm's geographic investment focus?
The firm maintains offices in San Francisco, New Brunswick, Indianapolis, Boston, and Larkspur in the US, plus Moscow in Russia and Melbourne in Australia. This implies a global mandate with a significant US tilt, plus selective exposure in Europe and the Asia-Pacific region. No public data specifies allocation percentages.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: